Aran Research & Development (1982) Ltd (ARAN) Fair Value & Analysis
Industrials · Il · Market cap 195M ILA
Fair value as of: Jul 18, 2026
From 13 valuation models · updated 23 days ago
Share price +12.2% over the past month.
A strong business, screening 68% undervalued on our models.
What matters now
- The rarer combination: high quality (84/100) AND below fair value. That earns a closer look rather than a quick verdict.
- The price is below even our cautious bear case (52.69 ILA). The market is more pessimistic than our downside scenario.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.
How to read this chart
60‑month range 11.38 ILA – 41.76 ILA · fair‑value band 52.69 ILA – 87.81 ILA · the 41.76 ILA price screens below the 70.25 ILA fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 18, 2026.
Analysis
Aran Research & Development (1982) Ltd (ARAN) currently trades at 41.76 ILA, while our model-based Fair Value estimate is 70.25 ILA, implying the stock looks roughly 68.2% undervalued today. The Quality Score stands at 84/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Aran Research & Development (1982) Ltd generated revenue of 263M ILA at a net margin of 7.1%. Revenue grew 11.4% year over year. It earns a return on equity of 23.7%. The balance sheet holds a net cash position of 26.6M ILA. Fundamentals as of Jul 18, 2026
Our scenario range runs from 52.69 ILA (bear case) to 87.81 ILA (bull case); at 41.76 ILA, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Industrials peers we cover trades at -14% fair-value upside, at 68%, ARAN screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: DCF Models (125.33 ILA) versus Asset-Based (14.03 ILA). Highest evidence: Growth DCF (80).
Notify me when ARAN reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 82 · Market factors (momentum, volatility) 83
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Aran Research & Development (1982) Ltd. engages in the product design and development, and equipment manufacturing businesses for plastics industry in Israel. It operates through Investments in Ventures and Start-Up Companies; Sale of Equipment and Raw Materials; and Product Development, Design, and Manufacturing Services segments.
Full company description
Aran Research & Development (1982) Ltd. engages in the product design and development, and equipment manufacturing businesses for plastics industry in Israel. It operates through Investments in Ventures and Start-Up Companies; Sale of Equipment and Raw Materials; and Product Development, Design, and Manufacturing Services segments. The company develops various medical devices; water devices and fluid management systems, including pressure and flow regulators, electric and hydraulic valves, air release valves, sprinklers, drippers, taps, water meters, filters, check valves, electronic controllers, and testing devices; and measurement and weighing devices, specialty printers, automatic beverage machines, computerized shopping carts and self-checkout kiosks, industrial and communication devices, and batteries. It also provides plastic sheets for agriculture, food and industrial packaging, pipes, and other technical products; technical support, training, analysis, after sales, logistics, and other services; and technological consulting, and software and computing personnel placement services. In addition, the company supplies machines and equipment, such as injection molding machines, robotics and automation, injection molds, hot runner systems, drying dosing and conveying systems, plasticizing screws barrels, ultrasonic welding and cleaning, and raw materials; designs, manufactures, and imports injection molds; and invests in medical start-up companies. It serves government ministries and public bodies; and the defense, medical and biotechnology, printing, water and agricultural, and consumer products industries. The company was formerly known as Aran Consulting and Development (1982) Ltd. and changed its name to Aran Research & Development (1982) Ltd. in May 1994. Aran Research & Development (1982) Ltd. was incorporated in 1982 and is based in Caesarea, Israel.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Aran Research & Development (1982) Ltd reported revenue of 263M ILA in FY2025 versus 206M ILA in FY2021, a compound +6.4%/yr. Reported net income was 18.7M ILA in FY2025, compounding +14.3%/yr from FY2021.
of which total revenue +9.3 pp · buybacks/dilution +0.1 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch ARAN: get an alert when its fair value changes →
Peer Group
Conglomerates · 369 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Conglomerates median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| CITIC Limited 0267 | HK$11.28 | HK$22.56 | +100% |
| SK Inc 034730 | 580,000 KRW | 497,919 KRW | -14% |
| PT Astra International Tbk, ASII | 4,810 IDR | 9,620 IDR | +100% |
| The Siam Cement Public Company SCC | 254.00 THB | 199.40 THB | -21% |
| SRF Limited SRF | ₹2,875 | ₹1,053 | -63% |
| Empresas Copec S.A COPEC | 6,330 CLP | 10,879 CLP | +72% |
| Posco International Corporation 047050 | 50,900 KRW | 61,248 KRW | +20% |
| Tube Investments of India Limited TIINDIA | ₹2,940 | ₹559.30 | -81% |
| Doosan Corporation 000155 | 464,000 KRW | 75,620 KRW | -84% |
| Thermax Limited THERMAX | ₹4,809 | ₹1,087 | -77% |
Compare Aran Research & Development (1982) Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Aran Research & Development (1982) Ltd (ARAN) overvalued or undervalued?
What is the fair value of ARAN?
What is the quality score of ARAN?
What is the revenue of Aran Research & Development (1982) Ltd (ARAN)?
What is the net profit margin of ARAN?
Does Aran Research & Development (1982) Ltd pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Aran Research & Development (1982) Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.